title: Surgical treatment of anaplastic thyroid carcinoma. Our experience.
abstract: BACKGROUND
  In anaplastic thyroid carcinoma (ATC) surgical resection associated to radiotherapy and chemotherapy can ameliorate local disease control with occasional long-term survivals.
  
  
  METHODS
  Resection of the tumor was accomplished in 20 ATC patients, with no macroscopic (13 cases) or minimal residual neck disease infiltrating vital structures (7 cases). Ten of these patients (50%) had distant metastases. Sixteen cases were also treated with radiotherapy and chemotherapy, while in one patient only chemotherapy was possible; 2 patients refused further therapy; the last one is starting adjuvant treatment. Morbidity and survival were analysed, and compared with other 15 ATCs submitted to partial tumor debulking or not operated at all (control group).
  
  
  RESULTS
  Function of at least one laryngeal recurrent nerve was preserved in all 20 patients; none experienced permanent hypoparathyroidism. At last follow-up examination 17 patients had died and 3 were alive 1, 6 and 80 months after the operation, the latter being free of disease. Survival of dead patients ranged from 3 to 28 months (mean: 8 months). In the control group all patients died, survival ranging from 1 to 13 months (mean: 4 months). Actuarial analysis of survival showed a significant difference between the two groups (p = 0.0112); multivariate analysis of several prognostic factors confirmed that complete or near complete tumour resection was the most relevant.
  
  
  CONCLUSIONS
  Surgical resection is an important component of the multimodal treatment of ATC and should be attempted whenever possible.
authors.affiliation: A.O.U. San Giovanni battista della Cittá di Torino, Italy.
authors.forename: N
authors.initials: N
authors.lastname: Palestini
authors.forename: E
authors.initials: E
authors.lastname: Brignardello
authors.forename: M
authors.initials: M
authors.lastname: Freddi
authors.forename: A
authors.initials: A
authors.lastname: Piovesan
authors.forename: N S
authors.initials: NS
authors.lastname: Pipitone Federico
authors.forename: G
authors.initials: G
authors.lastname: Sisto
authors.forename: A
authors.initials: A
authors.lastname: Robecchi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D016022:Case-Control Studies; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D016019:Survival Analysis; D013964:Thyroid Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D013965:Thyroidectomy; D016896:Treatment Outcome